News
-
Babraham strengthens board to boost global influence
Three life science heavyweights have bolstered the board of Cambridge’s Babraham Bioscience Technologies as it seeks to grow the global influence of... Read More
-
Gallagher grabs honours as Cambridge University insurance partner
Education sector specialist Gallagher has been appointed as the broker partner for the University of Cambridge. The university includes six... Read More
-
Global guru named chief scientist of Cambridge Quantum Computing
World leading authority and Oxford don Bob Coecke has added yet another dimension to the non-stop progress of Cambridge Quantum Computing (CQC) by... Read More
-
Countrywide shareholders’ windfall from £130m Connells takeover
One of the biggest deals in the UK property arena in recent times has brought about the marriage of Beds-based Connells and Essex competitor... Read More
-
Cell and gene therapy lab ramps with £3m extra funding
A new cell and gene therapy integration laboratory in Stevenage is to receive more than £3 million from Hertfordshire LEP’s Getting Building Fund... Read More
-
Key from 2021: 8K TVs, women’s sport, Open RAN and Intelligent Edge technology
Deloitte predicts that one-million 8K TV’s will be sold in 2021, generating £2.5 billion in revenue globally, ushering in a new era for the small... Read More
-
Sky’s the limit in terms of new killer applications, say Arm chiefs
A birth in a barn is a topical theme at this time of year and, to extend the analogy, more than a few wise men have borne gifts to and from Arm after... Read More
-
From horror to honour: Arm experience will be with me forever
I was working at Texas Instruments and first heard about ARM around 1992. I had recently completed an MBA and had “gone commercial” doing marketing... Read More
-
Arm still barnstorming 30 years after humble birth
Reflecting on the early days of Arm has refreshed fond memories of exciting and challenging times, writes Sir Robin Saxby, first CEO of Arm. The... Read More
-
Harlow becomes home to new NVIDIA supercomputer
US technology giant NVIDIA, which expects to complete its $40 billion acquisition of Cambridge superchip architect Arm in 2021, has decided to site... Read More
-
Champagne and chips: Arm found the perfect recipe
Producing a new microprocessor from scratch at Acorn Computers seemed a mad project doomed to failure, writes Hermann Hauser, co-founder of Acorn... Read More
-
Sosei Heptares and GSK clinch $1/2bn immune disorders alliance
Cambridge-centric Sosei Heptares and global pharma giant GSK have signed a global collaboration and licensing deal targeting immune disorders of the... Read More
-
Canadians pay £8 million for Cambridge wellness enterprise
Law firm Birketts has advised the shareholders of Cambridge e-commerce wellness company Bloomboxclub on its sale to digital Canadian health... Read More
-
Barclays reveals £3.1 billion sales boost to region’s manufacturing industry
A boom in manufacturers selling direct-to-consumer (D2C) will provide a £3.1 billion boost to the East of England industry’s coffers by 2023,... Read More
-
TTP unveils innovative asthma and COPD inhaler
Cambridge technology innovator TTP plc has helped to create a ground-breaking new dry powder inhaler designed to be as cost-effective and easy-to-use... Read More
-
Cambridge Network rises to the challenge of a virtual jobs market
Cambridge Network’s recruitment team realised quite early in the pandemic that job searching and hiring were about to be challenged. To tackle the... Read More
-
American aviation beauty arrives for Marshall makeover
Marshall Aerospace and Defence Group has taken delivery of the first US Marine Corps aircraft to be inducted into its Cambridge headquarters for... Read More
-
EY grows fee income and parades diversity in bullish growth strategy
Following a strong performance over the first nine months of its financial year, pre COVID-19, EY has reported five per cent UK revenue growth and... Read More
-
Former Arm and Thales ace takes CQC cybersecurity role
Cambridge Quantum Computing (CQC) has appointed Duncan Jones as head of the company’s quantum cybersecurity business. He has extensive... Read More
-
Gyroscope board fortified by trio of life science stars
Gyroscope Therapeutics, the Stevenage based clinical-stage retinal gene therapy company, has strengthened its board with three appointments. Jennifer... Read More